Search alternatives:
significant negative » significant positive (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
negative decrease » negative breast (Expand Search)
significant negative » significant positive (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
negative decrease » negative breast (Expand Search)
-
2601
-
2602
-
2603
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2604
-
2605
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2606
-
2607
-
2608
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2609
-
2610
-
2611
-
2612
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2613
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2614
-
2615
-
2616
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2617
-
2618
-
2619
-
2620